Latest It Services News

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Comms Group Limited reports a strong start to FY26 with a 41.6% revenue increase and successful integration of TasmaNet, positioning the company for ambitious annual targets.

NEXTDC reported robust FY25 results with 14% revenue growth and unveiled an ambitious 3GW expansion pipeline across Australia and Asia, positioning itself at the forefront of the AI infrastructure revolution.

NEXTDC’s 2025 AGM highlights a landmark year with 42% growth in contracted utilisation and a $6.4 billion funding base, alongside strategic board changes and a new incentive plan to secure leadership.

NEXTDC’s FY25 Annual General Meeting reveals robust financial growth, significant data centre expansions, and enhanced funding capacity to capitalise on AI infrastructure demand.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, citing limited competition concerns amid evolving digital media landscapes.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, finding limited competition concerns amid evolving digital media landscapes.

ReNerve Limited’s innovative NervAlign® Nerve Cuff has secured approval for use across the US Department of Defense and Veterans Affairs healthcare systems, marking a major milestone for the Australian medtech company.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.

Pacific Current Group has confirmed key leadership appointments with Michael Clarke named Managing Director and CEO, and Ron Patel taking on the role of Acting CFO, signaling continuity and financial stewardship.